No results matched your search
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| BIIB | NASDAQ | USD | Real-time | |
| BIIB | Mexico | MXN | Delayed | |
| BIIB | Switzerland | CHF | Delayed | |
| BIIB | Berlin | EUR | Delayed | |
| BIIB | Xetra | EUR | Delayed | |
| BIIB | Frankfurt | EUR | Delayed | |
| BIIB | Munich | EUR | Delayed | |
| BIIB | TradeGate | EUR | Delayed | |
| BIIB | Stuttgart | EUR | Delayed | |
| BIIB34 | BM&FBovespa | BRL | Delayed | |
| BIIB | Vienna | EUR | Delayed |
Boehringer Ingelheim will collaborate with IBM (NYSE:IBM) to explore the use of blockchain technology in clinical trials, specifically to determine if blockchain can improve...
Biogen Inc. shares declined in the extended session Wednesday after the U.S. Patent and Trademark Office said Mylan NV could likely succeed in a patent challenge to a Biogen...
Biogen Inc. shares declined in the extended session Wednesday after the U.S. Patent and Trademark Office said Mylan NV could likely succeed in a patent challenge to a Biogen...
Alkermes plc. (NASDAQ:ALKS) reported adjusted earnings of 34 cents per share in the fourth quarter of 2018, outperforming the Zacks Consensus Estimate of a loss of 6 cents. The...
This year, biotech stocks have seen their best-ever start to a year since 2012. A solid merger-and-acquisition momentum has been instrumental in this rally. However, the momentum...
The fourth-quarter earnings season has crossed the half way mark. Per the latest Earnings Trend report, total earnings for the medical sector are up 11.3% from the same period last...
| Type | 5 mins | 15 mins | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Emerging Patterns | |||||
| Bullish Engulfing | 1W | Current | |||
| Completed Patterns | |||||
| Three Outside Down | 1D | 6 | Feb 07, 2019 | ||
| Doji Star Bearish | 1H | 6 | Feb 15, 2019 09:00AM | ||
| Engulfing Bearish | 1D | 7 | Feb 06, 2019 | ||
| Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| NASDAQ | 332.87 | 315.00 | 332.87 | 1,435,708 | +2.51% | USD | 15:59:59 | ||
| Mexico | 6,357.00 | 0.00 | 0.00 | 277 | +1.86% | MXN | 12:38:09 | ||
| Switzerland | 334.30 | 0.00 | 0.00 | 0 | +0.00% | CHF | 06/02 | ||
| Berlin | 291.54 | 0.00 | 0.00 | 0 | +2.12% | EUR | 13:35:00 | ||
| Xetra | 291.51 | 290.79 | 291.83 | 139 | +2.59% | EUR | 11:35:00 | ||
| Frankfurt | 289.58 | 0.00 | 0.00 | 0 | +2.36% | EUR | 09:52:00 | ||
| Munich | 286.52 | 0.00 | 0.00 | 37 | -0.06% | EUR | 05:56:00 | ||
| TradeGate | 291.45 | 293.41 | 295.22 | 51 | +2.51% | EUR | 13:35:00 | ||
| Stuttgart | 291.75 | 0.00 | 0.00 | 0 | +2.57% | EUR | 00:00:00 | ||
| BM&FBovespa | 200.79 | 0.00 | 0.00 | 0 | +0.00% | BRL | 13/02 | ||
| Vienna | 283.020 | 0.000 | 0.000 | 0 | +0.53% | EUR | 13/02 |
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| Apple | 170.42 | 171.70 | 169.75 | -0.38 | -0.22% | 24.63M | 15:59:59 | ||
| Alphabet A | 1,119.63 | 1,139.30 | 1,116.72 | -9.57 | -0.85% | 1.39M | 15:59:59 | ||
| 162.50 | 164.70 | 160.86 | -1.45 | -0.88% | 15.50M | 15:59:59 | |||
| Amazon.com | 1,607.95 | 1,628.91 | 1,604.50 | -14.70 | -0.91% | 4.34M | 15:59:59 | ||
| Alibaba | 166.15 | 168.77 | 165.41 | -2.23 | -1.32% | 12.10M | 15:59:59 | ||
| Barrick Gold | 12.95 | 13.00 | 12.70 | +0.04 | +0.31% | 12.38M | 15:59:59 | ||
| Microsoft | 108.22 | 108.30 | 107.36 | +1.32 | +1.23% | 26.61M | 15:59:59 | ||
| Kinross Gold | 3.490 | 3.490 | 3.230 | +0.230 | +7.06% | 15.46M | 15:59:59 | ||
| Agnico Eagle Mines | 43.140 | 43.180 | 41.980 | +1.280 | +3.06% | 1.68M | 15:59:59 | ||
| Suncor Energy | 33.89 | 34.05 | 33.01 | +1.34 | +4.12% | 6.17M | 15:59:59 |
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.
Read More| Brokers | Regulation | Minimum Deposit | |
|---|---|---|---|
 |
U.S. Commodity Futures Trading Commission (United States) | Start Trading | |
 |
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) | $0 | Start Trading |
 |
U.S. Commodity Futures Trading Commission (United States) | $250 | Start Trading |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
